European Journal of Pharmacology 2005-09-05

Peripheral participation of the phosphodiesterase 3 on formalin-evoked nociception.

Jorge E Torres-López, Vinicio Granados-Soto

Index: Eur. J. Pharmacol. 519(1-2) , 75-9, (2005)

Full Text: HTML

Abstract

The local peripheral (subcutaneous) injection of phosphodiesterase 3 inhibitor trequinsin dose-dependently enhanced formalin-evoked flinching during late second phase of this test. Treatment with the nitric oxide synthase inhibitor N-L-nitro-arginine methyl ester or guanylyl cyclase inhibitor 1-H-[1,2,4,]oxadiazolo[4,3-a]quinoxalin-1-one significantly reversed trequinsin-induced pronociceptive effect. Results suggest that the peripheral phosphodiesterase 3 may play an important physiologic role on inflammatory pain by controlling cyclic AMP levels and therefore the nociceptor threshold.

Related Compounds

Related Articles:

Pituitary adenylate cyclase activating polypeptide (PACAP) potently enhances tyrosine hydroxylase (TH) expression in adrenal chromaffin cells.

1994-01-01

[Life Sci. 54(22) , 1735-43, (1994)]

Atrial natriuretic peptide reduces cyclic AMP by activating cyclic GMP-stimulated phosphodiesterase in vascular endothelial cells.

1994-09-01

[J. Cardiovasc. Pharmacol. 24(3) , 351-7, (1994)]

Role of cGMP-inhibited phosphodiesterase and sarcoplasmic calcium in mediating the increase in basal heart rate with nitric oxide donors.

2000-10-01

[J. Mol. Cell. Cardiol. 32(10) , 1831-40, (2000)]

Effects of colforsin, trequinsin and isoprenaline on norepinephrine-induced contractions and cyclic nucleotide levels of isolated vascular tissue.

1988-02-01

[Arzneimittelforschung 38(2) , 240-3, (1988)]

Dissociation between phosphodiesterase inhibition and antiproliferative effects of phosphodiesterase inhibitors on the Dami cell line.

1997-04-25

[Biochem. Pharmacol. 53(8) , 1141-7, (1997)]

More Articles...